Left Ventricular Assist Results Lead Transplant MeetingLeft Ventricular Assist Results Lead Transplant Meeting
First-year performance results for the small implantable left ventricular assist device will be presented at the International Society for Heart and Lung Transplantation Scientific Sessions. Medscape Medical News
Conclusions ECMO as BTT has led to encouraging perioperative outcomes and early survival. Careful patient selection and early use of ECMO seems to allow for preservation of vitality while these critically ill candidates await donor organs, which may improve outcomes.
Invasive aspergillosis (IA) is a frequent complication in lung transplant recipients (LTRs). Clinical risk factors for IA have not been fully characterized, especially in the era of extensive antifungal prophylaxis.
We examined safety and long-term outcomes of intravenous treprostinil administered via the implantable LENUS Pro ® pump in patients with severe pulmonary hypertension (PH).
The Fried frailty phenotype is associated with morbidity and mortality in lung transplant (LTx) candidates, but its clinical application and association with post-transplant outcomes are not well defined. We aimed to assess two alternate frailty indices in LTx candidates and evaluate associations of frailty with early post-transplant outcomes and one-year mortality.
Ex Vivo Lung Perfusion (EVLP) is a system that circulates normothermic perfusate into procured lungs, allowing for improved lung function and lung assessment. We investigated whether ventilation with hydrogen gas during EVLP improves the donation after cardiac death (DCD) lung function, and whether this effect persists after actual transplantation.
Limited data exists describing impact of body mass index (BMI) on post-LVAD outcomes. We sought to define the relationship between BMI and adverse events (AE) following LVAD implantation by examining the ISHLT Mechanically Assisted Circulatory Support (IMACS) registry.
Image courtesy of Paragonix Technologies Many lungs being transported for transplant arrive in such bad shape that they cannot be used. Paragonix Technologies, Inc. aims to change that with SherpaLung, a specialized cooler that keeps lungs properly inflated and at the right temperature to survive an airplane trip. Paragonix Technologies just landed support from the Lung Transplant Foundation to continue developing and commercialize SherpaLung, the latest in its series of specialized organ transport carriers. Braintree, MA-based Paragonix launched similar devices for hearts and kidneys within the past several months, a...